Mylan says it will make available a generic version of its EpiPen, as criticism mounts over the price of its injectable medicine. The company said Monday that its U.S. subsidiary will put out a ...
Mylan and federal investigators Thursday finalized a $465 million settlement of charges the drugmaker overcharged the government for the injection allergy medication EpiPen. Resolving an issue that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results